Request appointment
353 East 68th StreetNew York, NY 10065
Overview of Dr. Kotecha
Dr. Ritesh Kotecha is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Bergen. He received his medical degree from Albany Medical College and has been in practice 12 years. He is one of 537 doctors at Memorial Sloan Kettering Cancer Center and one of 22 doctors at Memorial Sloan Kettering Bergen who specialize in Oncology. He has more than 70 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2014 - 2017
Albany Medical CollegeClass of 2014, MD
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2017 - 2028
NJ State Medical License 2020 - 2027
PA State Medical License 2023 - 2026
MA State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer Start of enrollment: 2020 Apr 06
Roles: Principal Investigator, Contact
- Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma Start of enrollment: 2019 Aug 22
Roles: Contact, Principal Investigator
- A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain Start of enrollment: 2023 Nov 10
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Advancing clinical trials for rare renal cell carcinoma subtypes: Consensus statements from the International Kidney Cancer Symposium North America 2025 think tank.Pavlos Msaouel, Salvatore La Rosa, Edwin Jason Abel, Laurence Albiges, Pedro C Barata
Urologic Oncology. 2026-09-12 - 3 citationsInfections in Patients with Solid Tumors Undergoing Adoptive Cellular Therapy.Viswatej Avutu, Jumanah N Algazaq, Kenneth Seier, Rhoena Desir-Camille, Li-Xuan Qin
Transplantation and Cellular Therapy. 2026-09-01 - Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management.Maria I Carlo, Andrew Schroeder, Jie Liu, Vignesh Ravichandran, Nikita Mehta
Journal of the National Cancer Institute. 2026-08-24
Authored Content
- Breaking down Genomic Data: An in-Depth Look at Ancestry and Tumor Biology in Kidney Cancer - Ritesh KotechaJuly 2023
Press Mentions
Sumanta Pal: Early Clinical Results of Xencor’s XmAb819 Presented at Targets25October 26th, 2025- CAR T-cell Therapy for Kidney Cancer Builds on Efficacy RecordNovember 9th, 2024
- Memorial Sloan Kettering Awards and AppointmentsOctober 16th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: